Tom T. Warner

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Clinical prognostic indicators in multiple system atrophy.

Clinical prognostic indicators in multiple system atrophy.

Journal: Brain : a journal of neurology

Published: September 09, 2025

Rare but Relevant: Assessing Variants in Dystonia-linked Genes in Parkinson's Disease.

Rare but Relevant: Assessing Variants in Dystonia-linked Genes in Parkinson's Disease.

Journal: medRxiv : the preprint server for health sciences

Published: July 17, 2025

Rare but Relevant? Assessing Variants in Dystonia-Linked Genes in Parkinson's Disease.

Rare but Relevant? Assessing Variants in Dystonia-Linked Genes in Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: July 07, 2025

Intronic FGF14 GAA repeat expansions impact progression and survival in multiple system atrophy.

Intronic FGF14 GAA repeat expansions impact progression and survival in multiple system atrophy.

Journal: Brain : a journal of neurology

Published: November 20, 2024

Author Correction: Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes.

Author Correction: Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes.

Journal: Nature communications

Published: November 13, 2024

Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes.

Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes.

Journal: Nature communications

Published: November 15, 2023

Differential LRRK2 signalling and gene expression in WT-LRRK2 and G2019S-LRRK2 mouse microglia treated with zymosan and MLi2.

Differential LRRK2 signalling and gene expression in WT-LRRK2 and G2019S-LRRK2 mouse microglia treated with zymosan and MLi2.

Journal: bioRxiv : the preprint server for biology

Published: September 25, 2023

Mutations in alpha-B-crystallin cause autosomal dominant axonal Charcot-Marie-Tooth disease with congenital cataracts.

Mutations in alpha-B-crystallin cause autosomal dominant axonal Charcot-Marie-Tooth disease with congenital cataracts.

Journal: European journal of neurology

Published: May 25, 2023

Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force - An Update.

Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force - An Update.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: November 25, 2021

The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy.

The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: November 10, 2021

jULIEs: nanostructured polytrodes for low traumatic extracellular recordings and stimulation in the mammalian brain.

jULIEs: nanostructured polytrodes for low traumatic extracellular recordings and stimulation in the mammalian brain.

Journal: Journal of neural engineering

Published: October 12, 2021

Opicapone Efficacy and Tolerability in Parkinson's Disease Patients Reporting Insufficient Benefit/Failure of Entacapone.

Opicapone Efficacy and Tolerability in Parkinson's Disease Patients Reporting Insufficient Benefit/Failure of Entacapone.

Journal: Movement disorders clinical practice

Published: February 11, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026